Undergraduate Courses: PCEUT 331

 

PHARMACEUTICS 331
Midterm Exam I

October 27 1997

Part I. (1 point each)

Mark A for TRUE and B for FALSE on your mark-sense form.

Note: MW's and formulae are listed on the last page.

1. A given set of measurements can be precise, but inaccurate. TRUE

2. At a given temperature and pressure only one crystal form of a drug will be stable. TRUE

3. Isothermic dissolution is a characteristic of a real solution. FALSE

4. Lactic acid (Ka = 1.38x10-4) is a weaker acid than acetic acid (pKa = 4.76). FALSE

5. Increasing solvent temperature will always increase drug solubility. FALSE

6. Amorphous preparation of insulin contains alpha and beta crystalline forms.FALSE

7. Amino acids are amphoteric electrolytes. TRUE

8. Osmolarity of 0.5% NaCl is identical to 0.5% H3BO3. FALSE

9. The 20 milli-equivalent sodium per liter listed in the urine chemistry report is the same as 20x10-3 M sodium. TRUE

10. Desmopressin, a polypeptide drug will be most soluble in a solution with pH value equal to its pI. FALSE

11. Addition of succinate group to prenisolone will reduce its solubility because succinate group will increase prenisolone's hydrophobicity. FALSE

12. When the pH of a solution is much greater than pKa of an acid, practically all the drug molecules will be in ionic form. TRUE

13. Lyophylization is a process of drying in which water is sublimed from the product after it is frozen. TRUE

14. For aqueous eye drops solutions, a sodium chloride equivalent range of .7-1.4% and pH range of 5.5-7.5 must be met for isotonicity. TRUE

PART II. MULTIPLE CHOICE QUESTIONS (2 points each)

Answer the following multiple choice questions by marking the mark-sense form with the correct choice. No points will be awarded to answers that are marked with more than one letter.

The nasal decongestant, Nostril (phenylephrine-HCl) 0.25% contains several inactive ingredients. Match functions listed in A-E with the ingredients listed in questions 15-16.

  • A. antioxidant

  • B. antimicrobial

  • C. viscosity increasing agent

  • D. buffer

  • E. surfactant

15. Benzalkonium chloride ________B___________

16. Boric acid and sodium borate ________D_________

17. To prepare a 7.5 µmole Morphine sulfate for epidural injection, you need to draw the following volume from a stock vial containing 15mg/ml or Morphine sulfate

  • A. 3.34 ml

  • B. 0.334 ml

  • C. 0.033 ml

  • D. 33.4 ml

  • E. None of the above

18. The therapeutic blood concentration of Digoxin is 0.5-2.0 ng/ml. Blood Digoxin concentration of 4 ng/ml or higher results in drug toxicity. Which of these statement(s) is (are) correct?

  • A. drug will have minimum therapeutic effects below 0.5 nM blood concentration

  • B. drug will induce toxicity above 5.12 nM blood concentration

  • C. therapeutic range is 0.64-2.56 nM

  • D. all of the above

  • E. A and B are correct

19. In a dispersed system the order of particle size is

  • A. solutions < emulsions < suspension

  • B. solutions < colloids < emulsions

  • C. colloids < emulsion < suspensions

  • D. all of the above

  • E. solutions > colloids > emulsions > suspension

20. Antiviral didanosine is inactivated in the acidic environment (pH 1-2) of stomach. You are asked to prepare 100 ml of didanosine oral solutions at pH 7.0 in sodium bicarbonate/carbonic acid buffer system (pKa = 6.1) to reduce drug degradation in stomach. How many moles of sodium bicarbonate must be added to 20mM carbonic acid to prepare 100 ml buffer at pH=7?

  • A. 0.159

  • B. 7.94

  • C. 0.0159

  • D. 1.588

  • E. 0.794

21. Pentobarbital is an acidic drug with pKa=8.1. At the physiologic condition of pH=7.4, the percentage of drug in the unionized form will be

  • A. 16.63%

  • B. 80%

  • C. 83.37%

  • D. 50%

  • E. none of the above

22. Surfactants are used in pharmaceutical formulations to

  • A. reduce viscosity

  • B. increase surface tension of solids

  • C. reduce interfacial tension between liquids

  • E. reduce interfacial tension between solid and liquid

  • E. C and D are correct.

23. Which of the following water is not required to be free of pyrogen?

  • A. Bacteriostatic Water for Injection, USP

  • B. Water for Injection, USP

  • C. Sterile Water for injection, USP

  • E. Purified Water, USP

  • E. none of the above

24. What is the osmolarity of an IV solution containing 12.5% Mannitol and 0.9% NaCl?

  • A. 307.7 mOsm/L

  • B. 686.8 mOsm/L

  • C. 500 mOsm/L

  • E. 994.5 mOsm/L

  • E. none of the above

25. Acyclovir is used to treat herpes virus infections in children at 80mg/kg/day. For a 15 kg child, you have prepared an oral suspension of 80mg/ml. How many teaspoons (tsp) would you ask the patient to take per day?

  • A. 1 tsp

  • B. 4 tsp

  • C. 3 tsp

  • D. 2 tsp

  • E. 6 tsp

26. How many grams of NaCl will be needed to make 200 ml of a Sulfonaimide combination solution containing 2% Sulfadiazine sodium (E value = 0.24) and 1% Sulfapyridine sodium (E value = 0.23) to be isotonic.

  • A. 0.38

  • B. 0.84

  • C. 1.6

  • D. 1.34

  • E. 1.8

27. You are consulted to compare a new peptide drug, Peptidsone with Prednisolone sodium phosphate injection . Prednisolone sodium phosphate is given at 20 mg injection dose. Assuming the distribution and metabolism profiles of both drugs to be similar, to provide a dose equivalent to Prednisolone sodium phosphate, you will choose the following dose for Peptidsone

  • i. 20 mg

  • ii. 62 mg

  • iii. 6 mg

  • iv. 41.3 µmoles

  • v. 2.5 x 1019 molecules

  • A. iii and iv

  • B. i, iv and v

  • C. iv only

  • D. ii, iv, and v

  • E. ii only

Rx Hyoscyamine sulfate 0.005

Lactose q.s. 0.200

Dispense such capsules XII

28. On the balance you have in your pharmacy, a 5mg weight moves the rest point one division. What is the minimum weighable quantity for your balance (with 5% error)?

  • A. 120 mg

  • B. 80 mg

  • C. 90 mg

  • D. 140 mg

  • E. none of the above

29. Using this balance and assuming you want to make 13 capsules with little wastage of lactose, you will weigh out the following amount of hyoscyamine sulfate and lactose:

  • A. 65 mg

  • B. 60 mg

  • C. 130 mg

  • E. 195 mg

30. The amount of lactose you will utilize in TOTAL (including that used above) in formulating this prescription will be:

  • A. 2.6 grams

  • B. 2.47 grams

  • C. 5.07 grams

  • E. 5.20 grams

31. If wastage of lactose is not an issue, you will use the following amount of lactose:

  • A. 2.335 grams

  • B. 2.535 grams

  • C. 5.07 grams

  • E. 5.20 grams

32. The amount of lactose in each of the dispensed capsules will be:

  • A. 3.1 grains

  • B. 3.0 grains

  • C. 5.6 grains

  • E. 5.2 grains

  • E. none of the above

FORMULAS

1 mole = 6.023 x1023 molecules



  Molecular Weight (g/mole)
Digoxin 780.92
H3BO3 61.83
Mannitol 182
Morphine Sulfate 668.76
NaCl 58.5
Peptidsone 1500.54
Prednisolone sodium phosphate 484.39

 


Pharmacy Home
|| Applying To The School || Contact Us

©2007 University of Washington School of Pharmacy